171 related articles for article (PubMed ID: 24013097)
1. miRNA-141, downregulated in pancreatic cancer, inhibits cell proliferation and invasion by directly targeting MAP4K4.
Zhao G; Wang B; Liu Y; Zhang JG; Deng SC; Qin Q; Tian K; Li X; Zhu S; Niu Y; Gong Q; Wang CY
Mol Cancer Ther; 2013 Nov; 12(11):2569-80. PubMed ID: 24013097
[TBL] [Abstract][Full Text] [Related]
2. miR-148b-3p functions as a tumor suppressor in GISTs by directly targeting KIT.
Wang Y; Li J; Kuang D; Wang X; Zhu Y; Xu S; Chen Y; Cheng H; Zhao Q; Duan Y; Wang G
Cell Commun Signal; 2018 Apr; 16(1):16. PubMed ID: 29661252
[TBL] [Abstract][Full Text] [Related]
3. miR-4299 inhibits tumor progression in pancreatic cancer through targeting ADAM17.
Liu J; Ye L; Lin K; Zhong T; Luo J; Wang T; Suo L; Mo Q; Li S; Chen Q; Yu Y
Mol Cell Biochem; 2023 Aug; 478(8):1727-1742. PubMed ID: 36565360
[TBL] [Abstract][Full Text] [Related]
4. Dichotomous role of the serine/threonine kinase MAP4K4 in pancreatic ductal adenocarcinoma onset and metastasis through control of AKT and ERK pathways.
Juin A; Spence HJ; Machesky LM
J Pathol; 2024 Apr; 262(4):454-466. PubMed ID: 38229581
[TBL] [Abstract][Full Text] [Related]
5. MiR-137 functions as a tumor suppressor in pancreatic cancer by targeting MRGBP.
Ding F; Zhang S; Gao S; Shang J; Li Y; Cui N; Zhao Q
J Cell Biochem; 2018 Jun; 119(6):4799-4807. PubMed ID: 29331027
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells.
Ji Q; Hao X; Zhang M; Tang W; Yang M; Li L; Xiang D; Desano JT; Bommer GT; Fan D; Fearon ER; Lawrence TS; Xu L
PLoS One; 2009 Aug; 4(8):e6816. PubMed ID: 19714243
[TBL] [Abstract][Full Text] [Related]
7. A link between mir-100 and FRAP1/mTOR in clear cell ovarian cancer.
Nagaraja AK; Creighton CJ; Yu Z; Zhu H; Gunaratne PH; Reid JG; Olokpa E; Itamochi H; Ueno NT; Hawkins SM; Anderson ML; Matzuk MM
Mol Endocrinol; 2010 Feb; 24(2):447-63. PubMed ID: 20081105
[TBL] [Abstract][Full Text] [Related]
8. Effects of miR-330 restoration on pancreatic cancer cells oncogenesis.
Farhadi A; Poursheikhani A; Heidari MF; Rajaeinejad M; Mosaed R; Faridfar A; Khosroshahi MA; Aslani P; Khalil-Moghaddam S; Behroozi J
Pathol Res Pract; 2024 Jun; 258():155337. PubMed ID: 38735276
[TBL] [Abstract][Full Text] [Related]
9. miR-147b is an oncomiR acting synergistically with HIPK2 to promote pancreatic carcinogenesis.
Wang G; Ma Z; Song C; Wang X; Zhou Z
Cell Signal; 2023 Nov; 111():110840. PubMed ID: 37543099
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-150 directly targets MUC4 and suppresses growth and malignant behavior of pancreatic cancer cells.
Srivastava SK; Bhardwaj A; Singh S; Arora S; Wang B; Grizzle WE; Singh AP
Carcinogenesis; 2011 Dec; 32(12):1832-9. PubMed ID: 21983127
[TBL] [Abstract][Full Text] [Related]
11. MiR-1271 Inhibits Ovarian Cancer Growth by Targeting Cyclin G1.
Liu X; Ma L; Rao Q; Mao Y; Xin Y; Xu H; Li C; Wang X
Med Sci Monit; 2015 Oct; 21():3152-8. PubMed ID: 26477861
[TBL] [Abstract][Full Text] [Related]
12. miR-431 Promotes Metastasis of Pancreatic Neuroendocrine Tumors by Targeting DAB2 Interacting Protein, a Ras GTPase Activating Protein Tumor Suppressor.
Zhang T; Choi S; Zhang T; Chen Z; Chi Y; Huang S; Xiang JZ; Du YN
Am J Pathol; 2020 Mar; 190(3):689-701. PubMed ID: 31953039
[TBL] [Abstract][Full Text] [Related]
13. Dominant Expression of DCLK1 in Human Pancreatic Cancer Stem Cells Accelerates Tumor Invasion and Metastasis.
Ito H; Tanaka S; Akiyama Y; Shimada S; Adikrisna R; Matsumura S; Aihara A; Mitsunori Y; Ban D; Ochiai T; Kudo A; Arii S; Yamaoka S; Tanabe M
PLoS One; 2016; 11(1):e0146564. PubMed ID: 26764906
[TBL] [Abstract][Full Text] [Related]
14. Gap junction beta-4 accelerates cell cycle progression and metastasis through MET-AKT activation in pancreatic cancer.
Muramatsu J; Arihara Y; Yoshida M; Kubo T; Nakamura H; Ishikawa K; Fujita H; Sugita S; Konno T; Kojima T; Kawano Y; Kobune M; Takada K
Cancer Sci; 2024 May; 115(5):1564-1575. PubMed ID: 38342100
[TBL] [Abstract][Full Text] [Related]
15. Expression of ZKSCAN3 protein suppresses proliferation, migration, and invasion of pancreatic cancer through autophagy.
Nonoyama K; Matsuo Y; Sugita S; Eguchi Y; Denda Y; Murase H; Kato T; Imafuji H; Saito K; Morimoto M; Ogawa R; Takahashi H; Mitsui A; Kimura M; Takiguchi S
Cancer Sci; 2024 Jun; 115(6):1964-1978. PubMed ID: 38671550
[TBL] [Abstract][Full Text] [Related]
16. Regulation of Nuclear Receptor Nur77 by miR-124.
Tenga A; Beard JA; Takwi A; Wang YM; Chen T
PLoS One; 2016; 11(2):e0148433. PubMed ID: 26840408
[TBL] [Abstract][Full Text] [Related]
17. MiR-22 is frequently downregulated in medulloblastomas and inhibits cell proliferation via the novel target PAPST1.
Xu QF; Pan YW; Li LC; Zhou Z; Huang QL; Pang JC; Zhu XP; Ren Y; Yang H; Ohgaki H; Lv SQ
Brain Pathol; 2014 Nov; 24(6):568-83. PubMed ID: 24576181
[TBL] [Abstract][Full Text] [Related]
18. MAP4K4 and WT1 mediate SOX6-induced cellular senescence by synergistically activating the ATF2-TGFβ2-Smad2/3 signaling pathway in cervical cancer.
Zheng H; Liu M; Shi S; Huang H; Yang X; Luo Z; Song Y; Xu Q; Li T; Xue L; Lu F; Wang J
Mol Oncol; 2024 May; 18(5):1327-1346. PubMed ID: 38383842
[TBL] [Abstract][Full Text] [Related]
19. Overcoming radioresistance of breast cancer cells with MAP4K4 inhibitors.
Kwon YS; Lee MG; Kim NY; Nam GS; Nam KS; Jang H; Kim S
Sci Rep; 2024 Mar; 14(1):7410. PubMed ID: 38548749
[TBL] [Abstract][Full Text] [Related]
20. Ciprofol suppresses proliferation, invasion and migration of human pancreatic cancer cells.
Han F; Dong S; Chen Z; Dong C; Shi H; Du Y; Zhou W
Pak J Pharm Sci; 2024 Mar; 37(2):327-336. PubMed ID: 38767100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
